 Physical training antiplatelet treatment stage II peripheral arterial occlusive disease efficacy physical antiplatelet therapy dipyridamole aspirin patients stage II peripheral arterial occlusive disease PAOD Patients following groups Group dipyridamole mg times mg daily Group physical exercise Group physical exercise dipyridamole mg time daily aspirin mg daily months treatment pain-free walking time PFWT maximum walking time MWT groups group PFWT MWT group PFWT MWT physical exercise drugs group PFWT MWT significant variations stage study ankle/arm pressure ratio rest standard treadmill exercise plethysmographic rest peak flows transcutaneous oxygen pressure basal conditions half recovery time induced ischemia results benefits regular exercise stage II PAOD patients antiplatelet therapy